Does ATORVASTATIN Cause Hyperbilirubinaemia? 138 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Hyperbilirubinaemia have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.2% of all adverse event reports for ATORVASTATIN.
138
Reports of Hyperbilirubinaemia with ATORVASTATIN
0.2%
of all ATORVASTATIN reports
11
Deaths
97
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From ATORVASTATIN?
Of the 138 reports, 11 (8.0%) resulted in death, 97 (70.3%) required hospitalization, and 21 (15.2%) were considered life-threatening.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)
Which ATORVASTATIN Alternatives Have Lower Hyperbilirubinaemia Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM